<DOC>
	<DOCNO>NCT01885533</DOCNO>
	<brief_summary>Thyroid dysfunction follow radioiodine Graves ' disease common , potentially detrimental avoidable . A variety clinical strategy employ post-radioiodine era util patient stable thyroid hormone replacement regimen , include use anti-thyroid drug , antithyroid drug thyroxine , early thyroxine replacement watchful monitoring onset hypothyroidism . Which effective avoiding dysthyroidism , unknown . This study aim address lack evidence . It focus Graves ' disease commonest cause thyrotoxicosis common indication RI therapy . It provide insight potential strategy improve important clinical outcome .</brief_summary>
	<brief_title>Post-Radioiodine Graves ' Management : The PRAGMA-Study</brief_title>
	<detailed_description />
	<mesh_term>Graves Disease</mesh_term>
	<criteria>Outpatients 18 year age , give write informed consent participate study Diagnosed Graves ' disease Received radioiodine treatment Graves ' disease Had minimum 12 month followup RI Most recent RI dose 5 year ago less time enrollment Patients unable give inform consent Age 17 year young Cause thyrotoxicosis Graves ' disease Patients one dose radioiodine include study , use data pertain recent treatment episode . Patients might adequately understand verbal explanation write information give English , special communication need</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Graves ' disease</keyword>
	<keyword>radioiodine</keyword>
	<keyword>thyroid</keyword>
	<keyword>hypothyroidism</keyword>
	<keyword>Graves ' orbitopathy</keyword>
</DOC>